Navigation Links
K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing Criteria
Date:7/20/2012

ST. LOUIS, July 20, 2012 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE: KVa/ KVb) ("the Company") today announced that on July 16, 2012 it was notified by the New York Stock Exchange Regulation, Inc., ("NYSE") that it is below listing standard criteria due to the Company's average market capitalization being less than $50 million over a 30-day trading period and its stockholder's equity being less than $50 million. Per NYSE regulations, K-V intends to submit a plan to the NYSE within 45 days of receipt of the notification to demonstrate its ability to achieve compliance with these continued listing standards within 18 months of receipt of the notice.

In addition, the Company was notified by the NYSE that its Class B common shares are below criteria for the average closing price of a security of less than $1.00 over a consecutive 30-day trading period. The Company will have a six-month period from the date of the NYSE notification to cure the deficiency related to its Class B common shares. Per NYSE procedures, K-V intends to notify the NYSE within 10 business days from the receipt of the NYSE notification of its intent to cure the deficiency related to its Class B common shares within the six-month cure period.  

As previously announced on June 29, 2012, the Company's Class A common shares are below criteria for the average closing price of a security of less than $1.00 over a consecutive 30 day trading period. The Company informed the NYSE of its intent to cure this deficiency within the six-month cure period on July 10, 2012.

About K-V Pharmaceutical Company

K-V Pharmaceutical Company is a specialty branded pharmaceutical company with a primary focus in the area of women's healthcare.   As such, we are committed to advancing the health of women across all the stages of their lives.

For further information about K-V Pharmaceutical Company, please visit the Company's corporate Website at

SOURCE K-V Pharmaceutical Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
4. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
5. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
6. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
7. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
8. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
9. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
10. Icahn Issues Statement Regarding Amylin Pharmaceuticals
11. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)...   NuAire , a manufacturer of ergonomically designed laboratory equipment ... of Japan to sell and service ... . NuAire will utilize its network of sales professionals throughout ... to offer assistance in application use, product benefits and features, ...
(Date:1/14/2014)... Oligomerix, Inc. , a privately held company pioneering the ... and related neurodegenerative disorders, announced today the relocation of ... as of January 15, 2014 and expanded lease ... College. Oligomerix, which is focused on the ...
(Date:1/14/2014)... Evidera , a leading provider of evidence-based solutions for ... Evaluation and Research (CDER), U.S. Food and Drug Administration, ... a patient-reported outcome (PRO) measure in drug development: ... for Measurement of Symptoms of Acute Bacterial Exacerbation of ...
Breaking Medicine Technology:NuAire announces sales and service of Hitachi Koki centrifuges in North America 2Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 2Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 3Evidera Announces Release of FDA Draft Guidance on Use of the "EXACT" to Measure Symptoms of COPD Exacerbations 4
... Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ), announced ... drug designation for tasimelteon, an oral dual melatonin receptor ... Disorder (N24HSWD) in blind individuals with no light perception. ... the Committee for Orphan Medicinal Products (COMP) of the ...
... BrainScope Company, Inc. announced today that it is ... product in development to aid in the assessment of ... the potential to represent a significant advancement in the ... injury (TBI) (including its milder forms commonly referred to ...
Cached Medicine Technology:Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 2Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 4BrainScope® Prepares to Introduce Ahead™ EU-100 to Aid in Assessment of Head Injury in the United Kingdom 2BrainScope® Prepares to Introduce Ahead™ EU-100 to Aid in Assessment of Head Injury in the United Kingdom 3
(Date:7/9/2014)... older age with kidney and heart disease have raised ... older adults. However, in the first study to look ... of Medicine at the University of Pennsylvania report that ... life expectancy and cardiovascular health as very healthy older ... of the ever increasing organ transplant waitlists, the authors ...
(Date:7/9/2014)... 2014 A study published in the scientific journal ... Robert Bonin, two researchers at Universit Laval, reveals that ... new method that involves rekindling pain so that it ... novel means to alleviate chronic pain. , The researchers ... Institut universitaire en sant mentale de Qubec (IUSMQ) were ...
(Date:7/9/2014)... from the Keck School of Medicine of the ... mice lacking a specific component of the immune ... fatal complication of infection. The discovery suggests that ... inflammation in human autoimmune and hyper-inflammatory diseases such ... The study was published online on June 23 ...
(Date:7/8/2014)... been awarded up to $15 million by the Defense ... project aiming to help brain-injured people restore lost memory ... neurobiology, psychology and physics will collaborate to create, surgically ... , Memory is the process in which neurons in ... and retrieve it. Certain types of illnesses and injuries ...
(Date:7/8/2014)... from Plymouth, UK, and Sydney, Australia, have today (Wednesday ... ACEmobile - a free-to-use app to support the assessment ... first of its kind; an iPad-based tool that supports ... the whole process, meaning more members of the clinical ... assessment. Designed by clinicians for clinicians, ACEmobile also collects ...
Breaking Medicine News(10 mins):Health News:Penn study finds living kidney donation does not increase risk of death or heart disease for older 2Health News:Discovery of a new means to erase pain 2Health News:DARPA awards UCLA $15 million to restore lost memory 2Health News:DARPA awards UCLA $15 million to restore lost memory 3Health News:New app widens opportunities for dementia assessments 2Health News:New app widens opportunities for dementia assessments 3
... May 1 As this week,s headlines have made it ... it comes to protecting yourself against flu outbreaks. What,s the ... thorough hand washing! According to the Centers for Disease Control ... "wash your hands often with soap and water, especially after ...
... patients lifetime of problems , , FRIDAY, May 1 (HealthDay ... getting a good night,s sleep could be in store ... , The study of 281 children, aged 10 to ... regardless of the severity of that condition, they were ...
... honors journalists for orthopaedic-related coverageROSEMONT, Ill., May 1 ... (AAOS) has announced the winners of its 2009 ... year and honors media efforts that further public understanding ... the care of bones, joints, muscles and tendons. ...
... Takes Place on the Eve of the 8th Annual National ... for 14 straight years, the teen birth rate in the ... in Washington, DC sponsored by The National Campaign to Prevent ... rate is increasing and will explore ways to try to ...
... Research supported by Shaklee Corporation, the number one natural ... blood vitamin D level is associated with metabolic syndrome ... are currently being presented at the National Lipid Association ... important role of vitamin D nutrition for maintaining cardiovascular ...
... Product Offering of Avalign Technologies, Inc.LAKE FOREST, ... ("RoundTable"), an operating-oriented private equity firm focused ... that its portfolio company, Avalign Technologies, ... instruments, implants, and delivery systems to the ...
Cached Medicine News:Health News:Protect Yourself with Hand Washing Help from Bath & Body Works 2Health News:Protect Yourself with Hand Washing Help from Bath & Body Works 3Health News:Treating Sleep Disorders May Ease ADHD Symptoms 2Health News:American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners 2Health News:American Academy of Orthopaedic Surgeons Announces Media Orthopaedic Reporting Excellence (MORE) Award Winners 3Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 2Health News:Forum Explores Solutions to the Rise in the Teen Birth Rate 3Health News:Vitamin D Linked to HDL Cholesterol - Shaklee Corporation Research Links Vitamin D with Key Biomarkers for Metabolic Syndrome and Heart Disease 2Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 2Health News:RoundTable Healthcare Partners Completes Portfolio Company Add-On Acquisition 3
Bone Curette, 180 mm...
Kevorkian Collector Endocervical Curette is a stainless-steel curette with rounded tip....
Kevorkian Endocervical Curette is a stainless-steel curette with a basket. It is narrow tipped for sampling without dilation....
...
Medicine Products: